Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mangoceuticals (MGRX) Change in Cash (2023 - 2025)

Historic Change in Cash for Mangoceuticals (MGRX) over the last 3 years, with Q3 2025 value amounting to $380307.0.

  • Mangoceuticals' Change in Cash rose 19145.64% to $380307.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $407785.0, marking a year-over-year increase of 13511.84%. This contributed to the annual value of -$670508.0 for FY2024, which is 129422.22% down from last year.
  • According to the latest figures from Q3 2025, Mangoceuticals' Change in Cash is $380307.0, which was up 19145.64% from $24335.0 recorded in Q2 2025.
  • Over the past 5 years, Mangoceuticals' Change in Cash peaked at $3.2 million during Q1 2023, and registered a low of -$1.7 million during Q3 2023.
  • For the 3-year period, Mangoceuticals' Change in Cash averaged around -$18136.4, with its median value being -$7077.0 (2024).
  • Its Change in Cash has fluctuated over the past 5 years, first tumbled by 12269.73% in 2024, then surged by 19145.64% in 2025.
  • Mangoceuticals' Change in Cash (Quarter) stood at -$497741.0 in 2023, then soared by 98.58% to -$7077.0 in 2024, then soared by 5473.84% to $380307.0 in 2025.
  • Its Change in Cash stands at $380307.0 for Q3 2025, versus $24335.0 for Q2 2025 and $10220.0 for Q1 2025.